Simulations Plus, Inc. (SLP)
USD 24.41
(-4.96%)
USD 24.41
(-4.96%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 37.02 Million USD | -5.61% |
| 2023 | 39.22 Million USD | 39.22% |
| 2022 | 28.17 Million USD | 14.46% |
| 2021 | 24.61 Million USD | 27.3% |
| 2020 | 19.33 Million USD | 35.25% |
| 2019 | 14.29 Million USD | 25.68% |
| 2018 | 11.37 Million USD | 18.91% |
| 2017 | 9.56 Million USD | 17.53% |
| 2016 | 8.13 Million USD | -0.04% |
| 2015 | 8.14 Million USD | 50.99% |
| 2014 | 5.39 Million USD | 23.91% |
| 2013 | 4.35 Million USD | 0.58% |
| 2012 | 4.32 Million USD | -17.44% |
| 2011 | 5.24 Million USD | -1.04% |
| 2010 | 5.29 Million USD | 5.7% |
| 2009 | 5 Million USD | 6.83% |
| 2008 | 4.68 Million USD | 9.76% |
| 2007 | 4.27 Million USD | 25.02% |
| 2006 | 3.41 Million USD | 15.93% |
| 2005 | 2.94 Million USD | -2.49% |
| 2004 | 3.02 Million USD | 12.75% |
| 2003 | 2.68 Million USD | 7.8% |
| 2002 | 2.48 Million USD | -2.6% |
| 2001 | 2.55 Million USD | -5.56% |
| 2000 | 2.7 Million USD | 6.99% |
| 1999 | 2.52 Million USD | -17.78% |
| 1998 | 3.07 Million USD | 27.54% |
| 1997 | 2.41 Million USD | 72.15% |
| 1996 | 1.4 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.88 Million USD | -29.09% |
| 2024 Q3 | 11.37 Million USD | 29.59% |
| 2024 Q4 | - USD | -29.89% |
| 2024 Q2 | 8.77 Million USD | -1.23% |
| 2023 Q4 | 12.53 Million USD | 36.61% |
| 2023 Q1 | 8.41 Million USD | 0.62% |
| 2023 FY | 39.22 Million USD | 39.22% |
| 2023 Q2 | 9.09 Million USD | 8.09% |
| 2023 Q3 | 9.17 Million USD | 0.88% |
| 2022 Q1 | 5.87 Million USD | -14.72% |
| 2022 FY | 28.17 Million USD | 14.46% |
| 2022 Q4 | 8.36 Million USD | 12.19% |
| 2022 Q3 | 7.45 Million USD | 14.92% |
| 2022 Q2 | 6.48 Million USD | 10.49% |
| 2021 Q4 | 6.88 Million USD | 19.41% |
| 2021 Q1 | 5.21 Million USD | 11.92% |
| 2021 Q3 | 5.76 Million USD | -14.61% |
| 2021 Q2 | 6.75 Million USD | 29.38% |
| 2021 FY | 24.61 Million USD | 27.3% |
| 2020 Q4 | 4.66 Million USD | -19.29% |
| 2020 FY | 19.33 Million USD | 35.25% |
| 2020 Q1 | 4.03 Million USD | 6.72% |
| 2020 Q2 | 4.85 Million USD | 20.25% |
| 2020 Q3 | 5.77 Million USD | 18.9% |
| 2019 Q1 | 3.24 Million USD | 21.74% |
| 2019 Q2 | 3.53 Million USD | 8.77% |
| 2019 Q3 | 3.73 Million USD | 5.57% |
| 2019 Q4 | 3.78 Million USD | 1.46% |
| 2019 FY | 14.29 Million USD | 25.68% |
| 2018 Q4 | 2.66 Million USD | -14.26% |
| 2018 Q2 | 2.82 Million USD | 1.98% |
| 2018 FY | 11.37 Million USD | 18.91% |
| 2018 Q1 | 2.76 Million USD | -2.72% |
| 2018 Q3 | 3.11 Million USD | 10.21% |
| 2017 Q3 | 2.2 Million USD | -6.28% |
| 2017 Q2 | 2.35 Million USD | 9.42% |
| 2017 Q1 | 2.15 Million USD | 13.5% |
| 2017 FY | 9.56 Million USD | 17.53% |
| 2017 Q4 | 2.84 Million USD | 28.88% |
| 2016 FY | 8.13 Million USD | -0.04% |
| 2016 Q1 | 2.02 Million USD | 9.23% |
| 2016 Q2 | 2.18 Million USD | 7.72% |
| 2016 Q4 | 1.89 Million USD | -6.48% |
| 2016 Q3 | 2.02 Million USD | -7.1% |
| 2015 Q2 | 1.97 Million USD | -15.63% |
| 2015 Q1 | 2.33 Million USD | 85.25% |
| 2015 FY | 8.14 Million USD | 50.99% |
| 2015 Q3 | 1.97 Million USD | -0.03% |
| 2015 Q4 | 1.85 Million USD | -5.9% |
| 2014 Q3 | 1.43 Million USD | -1.27% |
| 2014 FY | 5.39 Million USD | 23.91% |
| 2014 Q1 | 1.23 Million USD | 19.97% |
| 2014 Q2 | 1.45 Million USD | 18.19% |
| 2014 Q4 | 1.26 Million USD | -12.25% |
| 2013 Q3 | 1.11 Million USD | 0.68% |
| 2013 FY | 4.35 Million USD | 0.58% |
| 2013 Q1 | 1.11 Million USD | 7.45% |
| 2013 Q2 | 1.1 Million USD | -0.8% |
| 2013 Q4 | 1.02 Million USD | -7.39% |
| 2012 Q3 | 1.11 Million USD | -8.32% |
| 2012 FY | 4.32 Million USD | -17.44% |
| 2012 Q1 | 952.04 Thousand USD | -33.58% |
| 2012 Q2 | 1.22 Million USD | 28.24% |
| 2012 Q4 | 1.03 Million USD | -7.59% |
| 2011 Q1 | 1.27 Million USD | -4.99% |
| 2011 Q3 | 1.3 Million USD | 5.4% |
| 2011 Q2 | 1.23 Million USD | -2.79% |
| 2011 Q4 | 1.43 Million USD | 10.12% |
| 2011 FY | 5.24 Million USD | -1.04% |
| 2010 FY | 5.29 Million USD | 5.7% |
| 2010 Q4 | 1.33 Million USD | -1.09% |
| 2010 Q3 | 1.35 Million USD | 0.82% |
| 2010 Q2 | 1.34 Million USD | 5.95% |
| 2010 Q1 | 1.26 Million USD | 16.71% |
| 2009 Q1 | 1.2 Million USD | -6.21% |
| 2009 Q4 | 1.08 Million USD | -18.05% |
| 2009 Q3 | 1.32 Million USD | -5.27% |
| 2009 FY | 5 Million USD | 6.83% |
| 2009 Q2 | 1.39 Million USD | 15.93% |
| 2008 FY | 4.68 Million USD | 9.76% |
| 2008 Q4 | 1.28 Million USD | 10.37% |
| 2008 Q3 | 1.16 Million USD | 7.36% |
| 2008 Q2 | 1.08 Million USD | 217.42% |
| 2008 Q1 | 341.62 Thousand USD | -68.0% |
| 2007 Q2 | 1.15 Million USD | 22.56% |
| 2007 Q3 | 1.11 Million USD | -3.51% |
| 2007 Q4 | 1.06 Million USD | -4.0% |
| 2007 FY | 4.27 Million USD | 25.02% |
| 2007 Q1 | 940.4 Thousand USD | -3.04% |
| 2006 Q1 | 725.97 Thousand USD | -4.12% |
| 2006 FY | 3.41 Million USD | 15.93% |
| 2006 Q3 | 914.25 Thousand USD | 13.23% |
| 2006 Q2 | 807.45 Thousand USD | 11.22% |
| 2006 Q4 | 969.86 Thousand USD | 6.08% |
| 2005 Q4 | 757.21 Thousand USD | -2.74% |
| 2005 FY | 2.94 Million USD | -2.49% |
| 2005 Q2 | 666.66 Thousand USD | -10.59% |
| 2005 Q3 | 778.5 Thousand USD | 16.78% |
| 2005 Q1 | 745.63 Thousand USD | 15.36% |
| 2004 Q1 | 749.21 Thousand USD | -3.62% |
| 2004 Q4 | 646.34 Thousand USD | -12.65% |
| 2004 Q3 | 739.97 Thousand USD | -16.64% |
| 2004 Q2 | 887.73 Thousand USD | 18.49% |
| 2004 FY | 3.02 Million USD | 12.75% |
| 2003 Q2 | 680.53 Thousand USD | 11.11% |
| 2003 Q1 | 612.47 Thousand USD | -10.21% |
| 2003 Q3 | 613.98 Thousand USD | -9.78% |
| 2003 Q4 | 777.33 Thousand USD | 26.61% |
| 2003 FY | 2.68 Million USD | 7.8% |
| 2002 Q4 | 682.15 Thousand USD | 7.38% |
| 2002 FY | 2.48 Million USD | -2.6% |
| 2002 Q3 | 635.26 Thousand USD | 15.34% |
| 2002 Q2 | 550.78 Thousand USD | -11.05% |
| 2002 Q1 | 619.19 Thousand USD | -11.73% |
| 2001 FY | 2.55 Million USD | -5.56% |
| 2001 Q4 | 701.46 Thousand USD | 10.16% |
| 2001 Q3 | 636.76 Thousand USD | 1.76% |
| 2001 Q2 | 625.73 Thousand USD | -4.83% |
| 2001 Q1 | 657.48 Thousand USD | -2.35% |
| 2000 FY | 2.7 Million USD | 6.99% |
| 2000 Q1 | 662.72 Thousand USD | 25.67% |
| 2000 Q4 | 673.3 Thousand USD | 3.69% |
| 2000 Q3 | 649.31 Thousand USD | -9.64% |
| 2000 Q2 | 718.62 Thousand USD | 8.43% |
| 1999 Q2 | 600 Thousand USD | -14.29% |
| 1999 Q1 | 700 Thousand USD | 22.01% |
| 1999 FY | 2.52 Million USD | -17.78% |
| 1999 Q3 | 800 Thousand USD | 33.33% |
| 1999 Q4 | 527.34 Thousand USD | -34.08% |
| 1998 Q2 | 900 Thousand USD | 12.5% |
| 1998 FY | 3.07 Million USD | 27.54% |
| 1998 Q3 | 700 Thousand USD | -22.22% |
| 1998 Q4 | 573.72 Thousand USD | -18.04% |
| 1998 Q1 | 800 Thousand USD | 12.67% |
| 1997 FY | 2.41 Million USD | 72.15% |
| 1997 Q3 | 600 Thousand USD | 50.0% |
| 1997 Q2 | 400 Thousand USD | 0.0% |
| 1997 Q4 | 710.04 Thousand USD | 18.34% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | 1.4 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CareCloud, Inc. | 93.35 Million USD | 60.346% |
| Augmedix, Inc. | 40.3 Million USD | 8.15% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 97.123% |
| CareCloud, Inc. | 93.35 Million USD | 60.346% |
| HealthEquity, Inc. | 401.74 Million USD | 90.785% |
| iCoreConnect Inc. | 15.12 Million USD | -144.775% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 91.35% |
| Nutex Health, Inc. | 66.54 Million USD | 44.371% |
| Omnicell, Inc. | 534.79 Million USD | 93.078% |
| OneMedNet Corporation | 8.24 Million USD | -348.926% |
| Progyny, Inc. | 176.61 Million USD | 79.039% |
| Renalytix Plc | 29.04 Million USD | -27.475% |
| Schrödinger, Inc. | 318.14 Million USD | 88.364% |
| SOPHiA GENETICS SA | 117.73 Million USD | 68.558% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -18.692% |
| Ontrak, Inc. | 29.47 Million USD | -25.598% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.325% |
| Sharecare, Inc. | 225.97 Million USD | 83.618% |
| Aclarion, Inc. | 4.87 Million USD | -659.282% |
| CareMax, Inc. | 670.05 Million USD | 94.475% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -582.104% |
| Forian Inc. | 20.59 Million USD | -79.715% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -582.104% |
| HeartBeam, Inc. | 15.31 Million USD | -141.74% |
| GeneDx Holdings Corp. | 224.28 Million USD | 83.494% |
| SCWorx Corp. | 2.71 Million USD | -1261.16% |
| Minerva Surgical, Inc. | 58.14 Million USD | 36.327% |
| Definitive Healthcare Corp. | 546.47 Million USD | 93.226% |
| 10x Genomics, Inc. | 674.94 Million USD | 94.515% |
| Zhongchao Inc. | 13.92 Million USD | -165.901% |
| Accolade, Inc. | 306.51 Million USD | 87.922% |
| MSP Recovery, Inc. | 565.43 Million USD | 93.453% |
| R1 RCM Inc. | 336.6 Million USD | 89.002% |
| Spok Holdings, Inc. | 90.97 Million USD | 59.309% |
| Privia Health Group, Inc. | 134.31 Million USD | 72.439% |
| EUDA Health Holdings Limited | 4.8 Million USD | -670.748% |
| TruBridge, Inc. | 206.17 Million USD | 82.044% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 97.123% |
| Sharecare, Inc. | 225.97 Million USD | 83.618% |
| Health Catalyst, Inc. | 258.73 Million USD | 85.692% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 94.788% |
| Premier, Inc. | 683.65 Million USD | 94.585% |
| HealthStream, Inc. | 168.02 Million USD | 77.967% |
| Certara, Inc. | 254.08 Million USD | 85.43% |
| GeneDx Holdings Corp. | 224.28 Million USD | 83.494% |
| Ontrak, Inc. | 29.47 Million USD | -25.598% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -8.034% |
| CareCloud, Inc. | 93.35 Million USD | 60.346% |
| EUDA Health Holdings Limited | 4.8 Million USD | -670.748% |
| HeartBeam, Inc. | 15.31 Million USD | -141.74% |
| Mangoceuticals, Inc. | 9.65 Million USD | -283.611% |
| CareMax, Inc. | 670.05 Million USD | 94.475% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -104.248% |
| National Research Corporation | 52.52 Million USD | 29.513% |
| Aclarion, Inc. | 4.87 Million USD | -659.282% |
| OptimizeRx Corporation | 69.3 Million USD | 46.581% |